Discovery of Allosteric and Selective Inhibitors of Inorganic Pyrophosphatase from Mycobacterium tuberculosis

被引:16
|
作者
Pang, Allan H. [1 ]
Garzan, Atefeh [1 ]
Larsen, Martha J. [2 ]
McQuade, Thomas J. [2 ]
Garneau-Tsodikova, Sylvie [1 ]
Tsodikov, Oleg V. [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 South Limestone St, Lexington, KY 40536 USA
[2] Univ Michigan, High Throughput Screening Lab, Ctr Chem Genom, Inst Life Sci, Ann Arbor, MI 48109 USA
关键词
FAMILY-II PYROPHOSPHATASES; ESCHERICHIA-COLI; FLUORIDE INHIBITION; PURIFICATION; MECHANISM; ENZYME; ANALOGS; SYSTEM; GROWTH; SITE;
D O I
10.1021/acschembio.6b00510
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inorganic pyrophosphatase (PPiase) is an essential enzyme that hydrolyzes inorganic pyrophosphate (PP;), driving numerous metabolic processes. We report a discovery of an allosteric inhibitor (2,4-bis (aziridin-l-yl)-6- (1-phenylpyrrol-2-yl)-striazine) of bacterial PPiases. Analogues of this lead compound were synthesized to target specifically Mycobacterium tuberculosis (Mtb) PPiase (MtPPiase). The best analogue (compound 16) with a K-i of 11 mu M for MtPPiase is a species-specific inhibitor. Crystal structures of MtPPiase in complex with the lead compound and one of its analogues (compound 6) demonstrate that the inhibitors bind in a nonconserved interface between monomers of the hexameric MtPPiase in a yet unprecedented pairwise manner, while the remote conserved active site of the enzyme is occupied by a bound PP; substrate. Consistent with the structural studies, the kinetic analysis of the most potent inhibitor has indicated that it functions uncompetitively, by binding to the enzyme substrate complex. The inhibitors appear to allosterically lock the active site in a closed state causing its dysfunctionalization and blocking the hydrolysis. These inhibitors are the first examples of allosteric, species-selective inhibitors of PPiases, serving as a proof-of-principle that PPiases can be selectively targeted.
引用
收藏
页码:3084 / 3092
页数:9
相关论文
共 50 条
  • [21] Discovery of selective inhibitors of imidazole glycerol phosphate dehydratase from Mycobacterium tuberculosis by docking-based virtual screening
    Podshivalov, D.
    Timofeev, V.
    Sidorov-Biryukov, D.
    Mandzhieva, I.
    Kuranova, I.
    FEBS JOURNAL, 2017, 284 : 310 - 310
  • [22] Inactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric Inhibitors
    Favrot, Lorenza
    Lajiness, Daniel H.
    Ronning, Donald R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (36) : 25031 - 25040
  • [23] STEREOSPECIFICITY OF ALLOSTERIC NADH DEHYDROGENASE FROM MYCOBACTERIUM TUBERCULOSIS
    WORCEL, A
    GOLDMAN, DS
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1967, 118 (02) : 420 - +
  • [24] Analysis of stress- and host cell-induced expression of the Mycobacterium tuberculosis inorganic pyrophosphatase
    Triccas J.A.
    Gicquel B.
    BMC Microbiology, 1 (1) : 1 - 5
  • [25] A novel non-radioactive primase-pyrophosphatase activity assay and its application to the discovery of inhibitors of Mycobacterium tuberculosis primase DnaG
    Biswas, Tapan
    Resto-Roldan, Esteban
    Sawyer, Sean K.
    Artsimovitch, Irina
    Tsodikov, Oleg V.
    NUCLEIC ACIDS RESEARCH, 2013, 41 (04)
  • [26] Polypharmacology-Driven Discovery and Design of Highly Selective, Dual and Multitargeting Inhibitors of Mycobacterium tuberculosis - A Review
    Amandy, Franklin V.
    Neri, Gabriel Luis L.
    Manzano, Joe Anthony H.
    Go, Adrian D.
    Macabeo, Allan Patrick G.
    CURRENT DRUG TARGETS, 2024, 25 (09) : 620 - 634
  • [27] Targeting of Fumarate Hydratase from Mycobacterium tuberculosis Using Allosteric Inhibitors with a Dimeric-Binding Mode
    Whitehouse, Andrew J.
    Libardo, M. Daben J.
    Kasbekar, Monica
    Brear, Paul D.
    Fischer, Gerhard
    Thomas, Craig J.
    Barry, Clifton E., III
    Boshoff, Helena I. M.
    Coyne, Anthony G.
    Abell, Chris
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (23) : 10586 - 10604
  • [28] Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors
    De Clercq, Dries J. H.
    Heppner, David E.
    To, Ciric
    Jang, Jaebong
    Park, Eunyoung
    Yun, Cai-Hong
    Mushajiang, Mierzhati
    Shin, Bo Hee
    Gero, Thomas W.
    Scott, David A.
    Janne, Pasi A.
    Eck, Michael J.
    Gray, Nathanael S.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (11): : 1549 - 1553
  • [29] Discovery of novel and highly selective allosteric inhibitors of PAK1
    Lindvall, Mika
    Karpov, Alexei
    Bellamacina, Cornelia
    Daniel, Dylan
    Fabbro, Doriano
    Fernandez, Cesar
    Jacob, Sandra
    Jahnke, Wolfgang
    Moebitz, Henrik
    Pecchi, Sabina
    Pecchi, Sabina
    Shoemaker, Kevin
    Wang, John
    Breitenstein, Werner
    Gutmann, Sascha
    Lagasse, Stephanie
    Machajewski, Timothy
    Marzinzik, Andreas
    Galuba, Inga
    Trappe, Joerg
    Crawford, Kenneth
    Voliva, Charles
    Lai, Albert
    Hinh, Linda
    Rummel, Gabriele
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [30] Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase
    Vanheusden, V
    Munier-Lehmann, H
    Froeyen, M
    Busson, R
    Rozenski, J
    Herdewijn, P
    Van Calenbergh, S
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) : 6187 - 6194